newsfilter
← Latest News
Business Wire·

Elan Issues Response Document Further Detailing Inadequacy of Royalty Pharma's Revised Offer

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) today issued a formal response document in respect of the Echo Pharma Acquisition Limited (Royalty Pharma) revised offer made on May 23, 2013. The response document is available on Elan’s website at www.elan.com.